A divided Congress and the retirement of one of the VALID Act's most prominent supporters in the Senate could make passing the bill a difficult lift.
Congress Reintroduces SALSA, Taking up PAMA Reform Once Again
A top priority for the lab industry, the bill was reintroduced this week by bipartisan groups of legislators in both the House and Senate.
An agency official said FDA is in the process of advancing plans to regulate laboratory-developed tests through the notice-and-comment rulemaking process.
While reform of lab-developed test regulations and PAMA appeared possible at the beginning of 2022, in the end, the status quo won out.
Lawmakers are still wrangling over whether to include these two key lab industry bills in an end-of-year spending package due to pass next week.